International Stem Cell Corporation: Revision history

20 August 2022

• curprev 04:0004:00, 20 August 2022 95.149.241.133 talk 1,983 bytes +11 No edit summary undo

13 August 2022

• curprev 04:1504:15, 13 August 2022 109.180.50.163 talk 1,972 bytes +15 No edit summary undo

10 August 2022

• curprev 07:0607:06, 10 August 2022 109.180.50.163 talk 1,957 bytes +1,957 Created page with "International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in North America, Asia, Europe, and internationally. The company's products are based on human parthenogenetic stem cells, a proprietary type of pluripotent stem cell. It develops various cell types, including neural stem cells for the treatment of Parkinson's disease and other central nervous system disorders; and develops, manuf..."